Ashford Capital Management Inc Incyte Corp Transaction History

Ashford Capital Management Inc

$733 Million
Q3 2024

A detailed history of Ashford Capital Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Ashford Capital Management Inc holds 240,640 shares of INCY stock, worth $17.1 Million. This represents 2.17% of its overall portfolio holdings.

Number of Shares

240,640

Previous 244,770 1.69%

Holding current value

$17.1 Million

Previous $14.8 Million 7.2%

% of portfolio

2.17%

Previous 2.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$57.33 - $68.61 $236,772 - $283,359	-4,130 Reduced 1.69%	240,640 $15.9 Million
Q2 2024 Aug 15, 2024	SELL	$51.18 - $63.75 $5.33 Million - $6.63 Million	-104,075 Reduced 29.83%	244,770 $14.8 Million
Q1 2024 May 15, 2024	SELL	$56.55 - $66.59 $1.35 Million - $1.59 Million	-23,924 Reduced 6.42%	348,845 $19.9 Million
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $3.97 Million - $4.88 Million	-76,075 Reduced 16.95%	372,769 $23.4 Million
Q3 2023 Nov 15, 2023	SELL	$57.77 - $65.93 $576,544 - $657,981	-9,980 Reduced 2.18%	448,844 $25.9 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $193,394 - $239,593	3,173 Added 0.7%	458,824 $28.6 Million
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $253,038 - $309,894	3,603 Added 0.8%	455,651 $32.9 Million
Q4 2022 Feb 15, 2023	BUY	$67.18 - $84.11 $1.28 Million - $1.61 Million	19,110 Added 4.41%	452,048 $36.3 Million
Q3 2022 Nov 15, 2022	SELL	$66.18 - $82.86 $1.26 Million - $1.58 Million	-19,023 Reduced 4.21%	432,938 $28.9 Million
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $233,085 - $292,959	3,522 Added 0.79%	451,961 $34.3 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $1.32 Million - $1.59 Million	19,924 Added 4.65%	448,439 $35.6 Million
Q4 2021 Feb 15, 2022	BUY	$63.34 - $74.11 $5.64 Million - $6.59 Million	88,970 Added 26.2%	428,515 $31.5 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $422,663 - $517,143	6,155 Added 1.85%	339,545 $23.4 Million
Q2 2021 Aug 26, 2021	SELL	$79.87 - $87.53 $164,132 - $179,874	-2,055 Reduced 0.61%	333,390 $28 Million
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $109,164 - $144,318	1,436 Added 0.43%	335,445 $27.3 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $7.6 Million - $9.2 Million	94,139 Added 39.25%	334,009 $29.1 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $520,117 - $670,644	-6,114 Reduced 2.49%	239,870 $21.5 Million
Q2 2020 Aug 17, 2020	SELL	$74.18 - $108.93 $2.36 Million - $3.46 Million	-31,805 Reduced 11.45%	245,984 $25.6 Million
Q1 2020 May 15, 2020	BUY	$63.18 - $85.97 $6.94 Million - $9.44 Million	109,813 Added 65.37%	277,789 $20.3 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $1.12 Million - $1.47 Million	15,353 Added 10.06%	167,976 $14.7 Million
Q3 2019 Nov 15, 2019	BUY	$72.82 - $86.52 $95,030 - $112,908	1,305 Added 0.86%	152,623 $11.3 Million
Q2 2019 Aug 15, 2019	SELL	$73.52 - $88.7 $115,426 - $139,259	-1,570 Reduced 1.03%	151,318 $12.9 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $2.26 Million - $3.14 Million	35,586 Added 30.34%	152,888 $13.2 Million
Q4 2018 Feb 15, 2019	SELL	$58.5 - $69.94 $3.15 Million - $3.77 Million	-53,853 Reduced 31.46%	117,302 $7.46 Million
Q3 2018 Nov 15, 2018	BUY	$61.75 - $74.23 $946,318 - $1.14 Million	15,325 Added 9.83%	171,155 $11.8 Million
Q2 2018 Aug 15, 2018	BUY	$60.85 - $83.98 $763,241 - $1.05 Million	12,543 Added 8.75%	155,830 $10.4 Million
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $3.65 Million - $4.44 Million	43,969 Added 44.27%	143,287 $11.9 Million
Q4 2017 Feb 15, 2018	SELL	$93.56 - $116.6 $158,116 - $197,054	-1,690 Reduced 1.67%	99,318 $9.41 Million
Q3 2017 Nov 15, 2017	SELL	$109.15 - $138.27 $101,400 - $128,452	-929 Reduced 0.91%	101,008 $11.8 Million
Q2 2017 Aug 21, 2017	BUY	N/A	101,937	101,937 $12.8 Million

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.

Account

Ashford Capital Management Inc Incyte Corp Transaction History